Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984256 · ClinicalTrials.gov registry record · Phase 2
Weekly Dosing of Malarone ® for Prevention of Malaria
A Phase 2 study of Malaria, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT00984256 is a Phase 2 study of Malaria that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 35 participants, below the 257-participant average among 27 other Malaria trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00984256, a Phase 2 study of Malaria, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether Malarone ®, which is a drug approved to prevent malaria when taken daily, will still effectively prevent malaria if taken weekly.
Conditions Studied
Interventions
- DRUG Atovaquone Proguanil
- OTHER Procedure - malaria challenge
Study Locations (1)
Maryland
- Walter Reed Army Institute of Research - Silver Spring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00984256
The ClinicalTrials.gov registry entry for NCT00984256 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 257-participant average among 27 other Malaria trials with a reported enrollment target (86% lower). The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malaria appearing as the primary indexed condition, and to 2 interventions - of which Atovaquone Proguanil is the first listed.
NCT00984256 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00984256 about?
NCT00984256 is a clinical study titled "Weekly Dosing of Malarone ® for Prevention of Malaria". The purpose of this study is to determine whether Malarone ®, which is a drug approved to prevent malaria when taken daily, will still effectively prevent malaria if taken weekly.
What is the current status of trial NCT00984256?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2009-09. Estimated completion is 2010-04.
What conditions does trial NCT00984256 study?
This clinical trial studies the following conditions: Malaria.
What interventions are being tested in trial NCT00984256?
The interventions under investigation include: Atovaquone Proguanil (DRUG), Procedure - malaria challenge (OTHER).
Who is sponsoring clinical trial NCT00984256?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00984256 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malaria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults
COMPLETED · Phase 2
-
Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults
COMPLETED · Phase 2
-
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
RECRUITING
-
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
RECRUITING
-
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
RECRUITING
-
A Study of Oral E1018 in Healthy Adult Participants
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.